In the recent global survey conducted by Stanford University, USA, Dr. Chittaranjan Patra’s name has been highlighted (in 2020, 2021 and 2022) as ‘World Top 2% most cited Scientists” in the area of Nanoscience and Nanotechnology.

Chittaranjan Patra received his B.Sc (1995) and M.Sc (1997) in Chemistry from the University of Burdwan, W.B. He was awarded the “Dr. Mrigendranath Ghosh Gold Medal” for obtaining first class and first rank in B.Sc Chemistry (Hons) Examination in 1995 from The University of Burdwan, India. He completed his Ph.D. in Chemistry in 2003 as CSIR Fellow (April 1998- March 2003) from National Chemical Laboratory (NCL), Pune. Thereafter, he received his postdoctoral experience (March 2003-October 2004) as ‘Nanotechnologist’ from Bar-Ilan University, Ramat-Gan, Israel. After that he moved to Mayo Clinic, Department of Biochemistry and Molecular Biology in October 2004 as postdoc followed by Assistant Professor in the same Department where Dr. Patra explored the field of nanobiotechnology for cancer and angiogenesis. Dr. Patra moved to CSIR-IICT-Hyderabad in 2010 after receiving prestigious Ramanujan Fellowship, from DST-New Delhi. Currently, Dr. Patra is working as Chief Scientist at Department of Applied Biology, CSIR-Indian Institute of Chemical Technology (IICT) and his research group is pursuing various translational nanomedicine research projects aimed at developing advanced nanomaterials and nanoparticles-based drug delivery systems (DDS) for treatment of cancer, cardiovascular & ischemic diseases, wounds and bacterial infections.  

    He has 129 peer-reviewed publications in high impact international journals (Google citations: 8703 h-index:50 & i-index: 110), 33 book chapters and 7 patents to his credit. Eight Ph.D. students (AcSIR) have been already awarded under his supervision. Currently, Dr. Patra is guiding 5 Ph.D. students. Additionally, he already trained 31 dissertation students of M.Sc., M.Pharm., M.Tech., B.Tech. and 9 ISc-INSA-NASI-Research Fellow. Dr. Patra served as invited reviewer for more than 55 various International journals including Advanced Materials, Chem.Soc.Rev., Advanced Drug Delivery Review, Biomaterials, Nanoscale, Organic Letters etc. Dr. Patra was the member of ACS, AACR, AAAS and life member of TAS, CRSI, ISCA, ISCB, CBS-India, ABAP, ICS and he has already delivered 54-invited lectures including 1 Plenary Lecture, 1 Key Note Address, 1 Guest Speaker, 1 Endowment Lecture. He serves as Editorial Board Member of ‘Biomedical Materials’ ‘Nanoscience and Nanotechnology’, ‘Gene Therapy and Molecular Biology (GTMB)’ and ‘Journal of Nanomedicine & Nanotechnology’. Apart from ‘Ramanujan Fellowship’ Dr. Patra received, ‘Young Investigator Award’, Michael A. O’Connor Travel Award’ from Mayo Clinic angiogenesis symposium, QRS Best Scientist Award from CSIR-IICT, and DR. DS Bhakuni Award from Indian Chemical Society. He has been elected as Fellow of Telangana Academy of Sciences and awarded for ‘CRS Silver Medal Award’. The World Science Congress (WSC), Kolkata felicitated Dr. Patra as ‘FLAME OF SCIENCE’ for lifetime contribution and excellence for the Noble Cause of Science. In the recent global survey conducted by Stanford University, USA, Dr. Patra’s name has been highlighted in three consecutive years since 2020 as ‘World Top 2% most cited Scientists” in the area of Nanoscience and Nanotechnology.

PEER-REVIEWED PUBLICATIONS (IN CHRONOLOGICAL ORDER).

Total publication: 162 (129+33) (including 33 Book Chapters)

 Total Patents: 7; USA Granted:5; Indian Granted:1; Pending (India/PCT):1

Research articles published in journal: 99

Research articles published in conferences: 8

Number of Review articles: 8

Number of Editorial/Commentary Article: 14 (13 +1)

Number of Published Book Chapters (in Elsevier/Wiley/Springer Nature/CRC etc.): 33

Co-Edited book on “Biogenic Nanoparticles for Cancer Theranostics” (Elsevier 2021)

Co-Edited Special issue on “Biomedical Materials Research in India” in Biomedical Materials (IOP Publisher)

Co-Edited Special issue on “Advances in Nanomedicine for Cancer Theranostics” in Biomedical Materials (IOP Publisher)

 Google Citations: 11556 & h index= 61, i-index = 130 in Google citations, as on September- 2025].  

Average Impact Factor of all publications (ISI 2020):              > 6